topotecan has been researched along with Kahler Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annibali, O; Avvisati, G; Cellini, F; Greco, R; Nobile, C; Petrucci, MT; Quattrocchi, CC; Tirindelli, MC | 1 |
| Anderlini, P; Champlin, RE; Donato, M; Giralt, SA; Hosing, C; Kazmi, SM; Popat, U; Qazilbash, MH; Qureshi, S; Saliba, RM; Wang, M | 1 |
| Aleman, A; Alexanian, R; Anagnostopoulos, A; Champlin, RE; de Lima, M; Donato, ML; Giralt, S; Ippoliti, CM; Weber, D | 1 |
| Farag, S; James, AG; Kraut, EH; Solove, RJ; Young, D | 1 |
| Cook, JM; Dalton, WS; Gump, JL; Hazlehurst, L; Marchion, D; Munster, P; Schell, MJ; Sullivan, DM; Turner, JG; Zhang, C | 1 |
| Aleman, A; Anderson, KO; Brown, J; Campagnaro, E; Cleeland, C; Giralt, S; Mendoza, F; Roden, L; Saliba, R; Weber, D | 1 |
| Karatapanis, S; Marinopoulos, S; Rasidakis, A; Skorda, L | 1 |
| Alsina, M; Crowley, JJ; Kraut, EH; Laufman, LR; Salmon, SE; Taylor, SA; Wade, JL | 1 |
3 trial(s) available for topotecan and Kahler Disease
| Article | Year |
|---|---|
Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Recurrence; Remission Induction; Topotecan; Transplantation, Autologous; Treatment Outcome | 2011 |
High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Pilot Projects; Remission Induction; Survival Rate; Topotecan; Transplantation, Autologous; Treatment Outcome | 2004 |
ABCG2 expression, function, and promoter methylation in human multiple myeloma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Blotting, Western; Cell Line, Tumor; DNA Methylation; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Male; Microscopy, Fluorescence; Multiple Myeloma; Neoplasm Proteins; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Topotecan; Transcription, Genetic; Up-Regulation | 2006 |
5 other study(ies) available for topotecan and Kahler Disease
| Article | Year |
|---|---|
The combination topotecan, temozolomide and dexamethasone associated with radiotherapy as treatment of central nervous system myeloma relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Dacarbazine; Dexamethasone; Fatal Outcome; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Myeloma; Recurrence; Temozolomide; Topotecan | 2009 |
Phase II study of topotecan and cyclophosphamide in patients with relapsed and refractory multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Resistance, Neoplasm; Female; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Salvage Therapy; Topotecan; Treatment Failure | 2005 |
Symptom burden after autologous stem cell transplantation for multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Middle Aged; Multiple Myeloma; Prospective Studies; Remission Induction; Severity of Illness Index; Survival Rate; Thiotepa; Topotecan; Transplantation, Autologous; Tumor Burden | 2008 |
Multiple myeloma emerging after chemotherapy for non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Humans; Lung Neoplasms; Male; Multiple Myeloma; Neoplasms, Second Primary; Taxoids; Topotecan; Vinblastine; Vinorelbine | 2008 |
Evaluation of topotecan in resistant and relapsing multiple myeloma: a Southwest Oncology Group study.
Topics: Adult; Aged; Antineoplastic Agents; Drug Resistance, Neoplasm; Female; Humans; Male; Middle Aged; Multiple Myeloma; Recurrence; Survival Rate; Topotecan | 1998 |